Single-session alcohol sclerotherapy in benign symptomatic hepatic cysts.

Abstract

PURPOSE:

To evaluate the results of single-session alcohol sclerotherapy in benign symptomatic liver cysts.

MATERIAL AND METHODS:

Ten cysts (volume 200-4,800 ml) in 10 patients were treated by percutaneous catheterization and injection of 96% ethanol at a dose of 10% of the cyst volume but never more than 100 ml. The treatment was applied for a maximum of 20 min, after which the alcohol and catheter were removed.

RESULTS:

A satisfactory reduction in cyst volume was achieved in all patients. In 8 patients there was a re-accumulation of fluid during the first period after therapy, followed by a significant reduction in volume on later follow-up examinations. Except for pain, there were no complications.

CONCLUSION:

Sclerotherapy as a single-session procedure resulted in a significant reduction in cyst volume in all 10 patients. The postprocedural re-accumulation of fluid seen in 8 patients proved to be temporary. It was not necessary to repeat the sclerotherapy procedure in any patient.

• Authors: T B Larssen, A Viste, D K Jensen, K Søndenaa, O Røkke, A Horn
• Journal: Acta radiologica (Stockholm, Sweden : 1987) (Acta Radiol) Vol. 38 Issue 6 Pg. 993-7 (Nov 1997) ISSN: 0284-1851 [Print] England
• PMID: 9394655 (Publication Type: Journal Article)

Chemical References

• Sclerosing Solutions
• Ethanol

Topics

• Adult
• Aged
• Aged, 80 and over
• Catheterization (instrumentation)
• Cysts (therapy)
• Ethanol (administration & dosage, adverse effects, therapeutic use)
• Exudates and Transudates
• Female
• Follow-Up Studies
• Humans
• Injections, Intralesional
• Liver Diseases (therapy)
• Male
• Middle Aged
• Pain (chemically induced)
• Remission Induction
• Sclerosing Solutions (administration & dosage, adverse effects, therapeutic use)
• Sclerotherapy (adverse effects)
• Time Factors